growth-capital
(4)
Andreessen Horowitz
Andreessen Horowitz did not become a $100 billion venture firm by treating a check as the finished product. Its real wager is that founders will choose the investor with the strongest machine behind the money.
Creizer
Creizer is a Mexico City fintech providing revenue-based financing to online sellers across Latin America. Often described as the Clear.co (formerly Clearbanc) for LATAM, it underwrites credit using a seller's daily sales and store metrics rather than traditional collateral, then collects repayment as a percentage of ongoing sales with no fixed installments or interest rates. Founded in 2021 by Emiliano Musalem and part of Y Combinator's Winter 2022 batch, Creizer offers credit lines from roughly 30,000 pesos up to several million, targeting the more than 80% of Latin American SMEs that lack access to conventional bank loans.
PvX Partners
PvX Partners is a Singapore-based fintech that provides non-dilutive user acquisition (UA) financing to mobile game studios and consumer app companies. Instead of equity or traditional debt, PvX funds a portion of a company's monthly marketing spend based on the historical performance of user cohorts, sharing downside risk if those cohorts underperform. Its financing is powered by Lambda, a proprietary machine-learning underwriting and intelligence platform, allowing profitable apps to scale user acquisition budgets without giving up ownership.
Clearco
Clearco is a Toronto-based fintech that gives ecommerce and direct-to-consumer brands fast, non-dilutive growth capital - founders raise money without giving up equity or signing personal guarantees. Using AI to read revenue, marketing spend and sales data, Clearco offers cash advances, invoice funding and rolling capacity repaid as a share of revenue. Founded in 2015 as Clearbanc by Michele Romanow and Andrew D'Souza, the company has deployed more than $3 billion to over 10,000 brands and, after a 2023 recapitalization, relaunched a rebuilt funding platform under CEO Andrew Curtis.